drugset / Trial / NCT00070148
Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
Phase 3
Completed
155 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedFactorialOpen-labelSupportive care
Summary
RATIONALE: Oxandrolone and megestrol may help prevent weight loss and improve quality of life in patients with cancer. It is not yet known whether oxandrolone is more effective than megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. PURPOSE: This randomized phase III trial is studying oxandrolone to see how well it works compared to megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors.
Timeline
- Start
- 2004-03-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Megestrol Acetate | Other / unclassified | 800 mg | Oral |
| Comparator | Oxandrolone | Small molecule | 20 mg | Oral |